INS and metabolic dysfunction-associated steatotic liver disease: Lifestyle changes, including changes in diet, weight loss, and increased physical activity, are currently the mainstay of treatment for MASLD; however, the potential of new pharmacological approaches that act on insulin signaling, hepatic lipid metabolism, and inflammation to improve treatment is encouraging.